Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Reviews

Acute kidney injury in liver cirrhosis: new definition and application

Florence Wong

Clin Mol Hepatol. 2016;22(4):415-422. Published online December 14, 2016

Web of Science 55 Crossref 59

DOI: https://doi.org/10.3350/cmh.2016.0056

New perspectives of biomarkers for the management of chronic hepatitis B

Chih-Lin Lin, Jia-Horng Kao

Clin Mol Hepatol. 2016;22(4):423-431. Published online December 25, 2016

Web of Science 49 Crossref 48

DOI: https://doi.org/10.3350/cmh.2016.0069

Management of direct antiviral agent failures

María Buti, Rafael Esteban

Clin Mol Hepatol. 2016;22(4):432-438. Published online December 25, 2016

Web of Science 29 Crossref 27

DOI: https://doi.org/10.3350/cmh.2016.0107

Editorial

Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination?

Byung-Cheol Song

Clin Mol Hepatol. 2016;22(4):439-442. Published online December 25, 2016

Web of Science 1 Crossref 1

DOI: https://doi.org/10.3350/cmh.2016.0108

Original Articles

Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)

Hye Won Lee, Jun Yong Park, Beom Kyung Kim, Moon Young Kim, Jung Il Lee, Young Suk Kim, Ki Tae Yoon, Kwang-Hyub Han, Sang Hoon Ahn

Clin Mol Hepatol. 2016;22(4):443-449. Published online November 25, 2016

Web of Science 10 Crossref 8

DOI: https://doi.org/10.3350/cmh.2016.0037

Comparison of hepatic MDCT, MRI, and DSA to explant pathology for the detection and treatment planning of hepatocellular carcinoma

Lauren M. Ladd, Temel Tirkes, Mark Tann, David M. Agarwal, Matthew S. Johnson, Bilal Tahir, Kumaresan Sandrasegaran

Clin Mol Hepatol. 2016;22(4):450-457. Published online December 14, 2016

Web of Science 6 Crossref 5

DOI: https://doi.org/10.3350/cmh.2016.0036

Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization

Sun Hong Yoo, Jeong Won Jang, Jung Hyun Kwon, Seung Min Jung, Bohyun Jang, Jong Young Choi

Clin Mol Hepatol. 2016;22(4):458-465. Published online December 25, 2016

Web of Science 10 Crossref 10

DOI: https://doi.org/10.3350/cmh.2016.0054

Emergency endoscopic variceal ligation in cirrhotic patients with blood clots in the stomach but no active bleeding or stigmata increases the risk of rebleeding

Su Jin Kim, Cheol Woong Choi, Dae Hwan Kang, Hyung Wook Kim, Su Bum Park, Young Mi Hong, Ki Tae Yoon, Mong Cho, Hyung Seok Nam, SM Bakhtiar UI Islam

Clin Mol Hepatol. 2016;22(4):466-476. Published online December 25, 2016

Web of Science 5 Crossref 5

DOI: https://doi.org/10.3350/cmh.2016.0063

Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma

Ju-Yeon Cho, Moon Seok Choi, Gil Sun Lee, Won Sohn, Jemma Ahn, Dong-Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik

Clin Mol Hepatol. 2016;22(4):477-486. Published online December 25, 2016

Web of Science 24 Crossref 21

DOI: https://doi.org/10.3350/cmh.2016.0048

Cyanoacrylate injection versus band ligation for bleeding from cardiac varices along the lesser curvature of the stomach

Sang Jung Park, Yong Kwon Kim, Yeon Seok Seo, Seung Woon Park, Han Ah Lee, Tae Hyung Kim, Sang Jun Suh, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jae Young Jang, Jong Eun Yeon, Kwan Soo Byun

Clin Mol Hepatol. 2016;22(4):487-494. Published online December 25, 2016

Web of Science 11 Crossref 10

DOI: https://doi.org/10.3350/cmh.2016.0050

Case Reports

A case of levocetirizine-induced liver injury

Moon Chan Jung, Ja Kyung Kim, Jae Yeon Cho, Jae Won Song, Bohyun Lee, Ji Won Park, Jinwon Seo, Sung Eun Kim

Clin Mol Hepatol. 2016;22(4):495-498. Published online December 25, 2016

Web of Science 2 Crossref 4

DOI: https://doi.org/10.3350/cmh.2016.0023

Recurrent acute portal vein thrombosis in liver cirrhosis treated by rivaroxaban

Hyeyoung Yang, Seo Ree Kim, Myeong Jun Song

Clin Mol Hepatol. 2016;22(4):499-502. Published online November 25, 2016

Web of Science 26 Crossref 23

DOI: https://doi.org/10.3350/cmh.2016.0016

Liver Pathology

Primary adenosquamous carcinoma of the liver: a case report

Kyung Han Nam, Ji Yeon Kim

Clin Mol Hepatol. 2016;22(4):503-508. Published online December 25, 2016

Web of Science 10 Crossref 11

DOI: https://doi.org/10.3350/cmh.2016.0077

Liver Imaging

Percutaneous cryoablation for hepatocellular carcinoma

Kyoung Doo Song

Clin Mol Hepatol. 2016;22(4):509-515. Published online December 25, 2016

Web of Science 43 Crossref 46

DOI: https://doi.org/10.3350/cmh.2016.0079

Viewed By 5957	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5447	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 5210	MAFLD: How is it different from NAFLD?
Viewed By 5198	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4769	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 208	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 145	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 119	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 107	MAFLD: How is it different from NAFLD?
Cited By 94	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Previous issues